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Introduction
Many researchers have investigated the re-
lationship between substance use and eat-
ing disorders over the last three decades. 
These reviews have highlighted co-occur-
rence of eating and substance problems 
(Krahn 1993); comorbidity of eating disor-
ders and substance use/abuse (Holderness 
et al. 1994); and comorbidity of substance 
use disorders and eating disorders (Harrop 
& Marlatt 2010). They have all focused on 
females in clinical or community settings. 
Briefly summarised, the reviewers con-
clude that there is an association among 
women between bulimic behaviour/bu-
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limia/non-restricting type of anorexia and 
an increased level of substance use/abuse, 
especially alcohol. Comorbid substance 
use disorders and eating disorders among 
adolescents have also been reviewed 
(Courbasson et al. 2010). In such studies, 
the categories of alcohol and drugs have 
to a large extent been collapsed (substance 
use/substance use disorders – SUD) or the 
reviews discuss only alcohol, obscuring 
the potential relationship between the use 
of particular substances/drugs and eat-
ing disorders. One recent meta-analysis 
on eating disorders and the use of drugs 
(Calero-Elvira et al. 2009) finds a small but 
significant increase of illicit substances 
(cannabis and opiates in particular) among 
the eating disorder population. 
Until now, no reviews have looked spe-
cifically at the double diagnosis of eating 
disorder and drug use disorders. From a 
drug field perspective, this focus is valu-
able in raising awareness of eating disor-
ders among drug disorder patients. This 
phenomenon has been given less attention 
in both research and clinical work (see, for 
example, Bonfa et al. 2008).
Several reviewers have commented on 
the problem of comparing studies that 
use different criteria for both substance 
abuse and eating disorders (for instance, 
Holderness et al. 1994; O’Brien & Vincent 
2003; Calero-Elvira et al. 2009). Different 
assessment techniques can generate differ-
ent categories, although this is not always 
made clear. My article attempts to address 
this problem by focusing on studies that 
apply the standard diagnostic systems 
(only the American Diagnostic and Statis-
tical Manual of Mental Disorders DSM is 
used).
Diagnoses
Diagnostic eating disorders include Ano-
rexia Nervosa, Bulimia Nervosa, Eating 
Disorders Not Otherwise Specified (DSM-
IV-TR 2000) and Binge Eating Disorder.1 
Anorexia Nervosa (AN) is characterised 
by a low body mass index, intense fear of 
gaining weight, a distorted body image and 
amenorrhea. AN is diagnostically divided 
into restricting and binge-eating/purging 
subtypes. Bulimia Nervosa (BN) is marked 
by recurrent episodes of binge eating, re-
current inappropriate behaviour in order 
to prevent weight gain (such as vomiting, 
use of laxatives, excessive exercise, fast-
ing), and a self-evaluation that is unduly 
influenced by body shape and weight. 
Eating Disorders Not Otherwise Specified 
(EDNOS) are applied to people who meet 
some, but not all, of the diagnostic criteria 
for AN or BN. For example, one may fulfill 
most of the criteria for Anorexia Nervosa 
but still retain a normal menstrual cycle. 
Binge Eating Disorder (BED) is a category 
within EDNOS, distinguished by repeated 
episodes of binge eating, including unusu-
ally large amounts of food and a sense of 
loss of control, and no compensatory be-
haviours (DSM-IV).
Diagnostic substance-related disorders 
according to DSM-IV-TR (2000) include 
the abuse or dependence on ampheta-
mines, cannabis, cocaine, hallucinogens, 
inhalants, opioids, phencyclidines (PCP), 
sedatives/hypnotics/anxiolytics (such as 
benzodiazepines, barbiturates), and poly-
substance. Abuse of or dependence on any 
of these drugs will be included in drug use 
disorders (DUD). DSM-IV also includes 
alcohol abuse or dependence under the 
heading of substance-related disorders.
Unauthenticated | 10.248.254.158
Download Date | 9/4/14 1:14 PM
305NORDIC STUDIES ON ALCOHOL AND DRUGS   V O L .  29.  2012 . 3
Etiology
The explanations for the comorbidity of 
eating disorders and substance use disor-
ders have most recently been discussed in 
terms of common or causal etiology. Most 
researchers have proposed not just one 
but several explanations for the comorbid-
ity, often in both categories of shared and 
causal etiology (for example, Carbaugh & 
Sias 2010; Wolfe & Maisto 2000; Holder-
ness et al. 1994). Personality traits such as 
novelty-seeking and reward sensitisation 
(Calero-Elvira et al. 2009) and impulsiv-
ity (Thompson-Brenner et al. 2008; Lacey 
1993) have been suggested as shared fac-
tors for eating disorders (BN in particular) 
and substance use. High interpersonal 
sensitivity (Carbaugh & Sias 2010) and 
neuroticism (high levels of negative af-
fect such as depression and anxiety, low 
self-esteem) (Baker et al. 2007) have also 
been put forward as common factors, as 
has insufficient affect regulation (Root et 
al. 2010b). Insecure attachment has been 
seen as a common trait (although differ-
ently resolved) in both eating disorder and 
drug disorder individuals (Miljkovitch et 
al. 2005). A common biological vulner-
ability, too, has been suggested (Carbaugh 
& Sias 2010).
Harrop & Marlatt (2010, 396) have dis-
cussed and dismissed the idea of shared 
factors, concluding that ”though sharing 
many facets, these disorders appear to be 
distinct”. Hypotheses have been proposed 
of causality both ways: individuals with 
eating disorders may be self-medicating 
their concerns about the disorder with 
alcohol and drugs, or their food-deprived 
brains may trigger substance use (Car-
baugh & Sias 2010; Krahn 1993). 
Methods
The databases Embase, Medline and Psyc-
Info were searched for studies published 
between January 1990 and May 2011, with 
combinations of the terms ’eating disor-
der’, ’substance-related disorder’, ’drug 
dependence’, ’drug abuse’, ’drug addic-
tion’ and ’substance abuse’. Only primary 
research articles in English or Scandina-
vian languages were considered (not in-
cluding reviews and dissertations). Both 
clinical and community studies were ac-
cepted, with adolescent or adult samples. 
This search yielded 596 articles (compris-
ing possible duplicates). The remaining 
screening of titles, abstracts and articles 
was done manually (see appendix). In-
cluded were studies in which diagnostic 
ED and diagnostic DUD were measured in 
the same sample and seen in relation to 
one another. The findings of possible con-
current or lifetime comorbidity had to be 
presented in percentages. Articles based 
on the same study sample were excluded. 
Thirteen articles could finally be included 
in the review.
Results
In 11 of the 13 studies included, ED was 
the primary diagnosis and DUD was sec-
ondarily measured. In two studies, DUD 
was the primary diagnosis, and ED was 
measured secondarily. The studies are 
presented in Table 1 and 2, respectively. 
They are sorted by year of publication 
and further described by author, sample, 
the DUD and ED diagnoses included, and 
the results in percentages (and odds ratios 
where included). Minor divergences from 
the DSM criteria for AN and BN diagnoses 
are allowed and commented upon in the 
tables.
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The 13 studies originate from the United 
States (9), Japan (1), New Zealand (1) and 
Spain (1). One study is transnational (Can-
ada, Germany, Italy and the USA). Eight 
of the studies have clinical samples; four 
have community samples; and one has 
one of each. Two studies are longitudinal. 
Only one study involves a non-clinical 
control group. Ten out of 13 samples in-
clude females only, and there is only one 
study in which the sample is predomi-
nantly male. The participants’ ages range 
between 11 and 68, with a majority in 
their late twenties.
In the two studies where the samples 
were initially diagnosed with drug use 
disorders, concurrent comorbidity of an 
eating disorder was 14 % in one study, and 
lifetime comorbidity 27.3 % in the other. 
The main eating disorder is Bulimia Ner-
vosa. In the studies in which samples were 
initially diagnosed with ED, the comorbid 
lifetime DUD varies from 8–43 % for vari-
ous drug disorders. The current abuse of/
dependence on specific drugs varies from 
0.5 % to 23.5 %. Nine studies separate be-
tween different kinds of ED, and in five of 
these, BN and bulimic/purging subtype of 
AN are significantly more comorbid with 
DUD than restricting AN is with DUD. In 
two studies, there were non-significant dif-
ferences, and the last two studies showed 
no differences between the various kinds 
of eating disorders. In the eight studies 
that separate between different drugs, the 
most prevalent drugs were cannabis, co-
caine and amphetamines. 
Discussion
The percentages of 8–43 of lifetime drug 
use disorders among individuals with an 
eating disorder are elevated compared 
to the general population. In the Ameri-
can National Comorbidity Survey (Kes-
sler et al. 1994), the lifetime prevalence 
of drug abuse/dependence according to 
DSM-IV criteria was 11.9 %, and last year 
prevalence was 3.6 %. A later replica-
tion study (Kessler et al. 2005) showed a 
10.9 % lifetime prevalence of drug abuse/
dependence. The only reviewed study 
that included a non-clinical control group 
showed an odds ratio for DUD of 2.0 (AN) 
and 2.4 (BN). The variations in sample 
size, participants, study setting and actual 
diagnoses in the included studies call for 
carefulness regarding the possibility of 
generalising the findings. The study with 
the lowest percentage (8.6 %) was con-
ducted in Japan, and the authors remark 
that drug use disorders in general, as well 
as in ED patients in particular, seem to be 
much less frequent than in Western popu-
lations (Nagata et al. 2002). 
14 % concurrent ED and 27.3 % life-
time ED in the two DUD samples is also 
much higher than in the general popula-
tion. According to DSM-IV-TR (2000), the 
lifetime prevalence for adult women is 
0.5 % for AN and 1–3 % for BN. In men, 
the frequence of these eating disorders is 
estimated to be around 10 % of the female 
prevalence (DSM-IV-TR 2000).
In this review, the vast majority of the 
samples are initially diagnosed with an 
eating disorder, and drug use disorders are 
then measured in this context. Previous 
reviews of substance use and eating disor-
ders show the same bias, with substantial-
ly fewer studies departing from substance 
use/abuse (Holderness et al. 1994; Krahn 
1993), or exclusively including eating dis-
order samples (Calero-Elvira et al. 2010; 
Courbasson et al. 2010). One of the reasons 
Unauthenticated | 10.248.254.158
Download Date | 9/4/14 1:14 PM
308 NORDIC STUDIES ON ALCOHOL AND DRUGS   V O L .  2 9.  2 0 1 2  . 3
Ta
bl
e 
2.
 S
tu
d
ie
s 
w
it
h
 d
ru
g 
u
se
 d
is
or
d
er
s 
as
 p
ri
m
ar
y 
d
ia
gn
os
is
.
St
ud
y
Sa
m
pl
e 
Dr
ug
 U
se
 D
iso
rd
er
Ea
tin
g 
Di
so
rd
er
Re
su
lts
Hu
ds
on
 e
t a
l. 
(1
99
2)
US
A
N=
38
6,
 
m
ale
 (2
43
)+
 fe
m
ale
 (1
43
)  
inp
at
ien
ts
 in
 s
ub
st
an
ce
  
tre
at
m
en
t, 
M
ea
n:
 3
4 
ye
ar
s
DS
M
-II
I d
ru
g 
di
so
rd
er
s,
 s
tim
ula
nt
s,
 
op
ioi
ds
, s
ed
at
ive
-h
yp
no
tic
s,
  
ca
nn
ab
is 
(+
 a
lco
ho
l) 
DS
M
-II
I-R
 d
iag
no
sis
  
(b
y q
ue
st
ion
na
ire
15
): 
AN
, B
N,
 A
N/
BN
 
27
.3
%
 o
f t
he
 s
tim
ula
nt
-a
dd
ict
ed
 w
om
en
 
ha
d 
a 
cu
rre
nt
 E
D 
di
ag
no
sis
 
(2
5%
 A
N,
 5
0%
 B
N,
 2
5%
 A
N/
BN
)
W
al
fis
h 
et
 a
l. 
(1
99
2)
US
A
N=
64
 fe
m
ale
 in
pa
tie
nt
s 
wi
th
  
dr
ug
 d
ep
en
de
nc
y (
+3
6 
wi
th
  
alc
oh
ol 
de
p.
), 
M
ea
n:
 3
4 
ye
ar
s
DS
M
-II
I-R
 d
ru
g 
de
pe
nd
en
ce
   
(c
an
na
bi
s,
 c
oc
ain
e,
 o
pi
oid
s,
 tr
an
qu
iliz
-
er
s) 
DS
M
-II
I-R
: 
BN
14
%
 o
f t
he
 g
ro
up
 o
f d
ru
g 
de
pe
nd
en
t 
re
po
rt 
cu
rre
nt
 B
N
19
%
 o
f t
he
 c
oc
ain
e 
de
pe
nd
en
t g
ro
up
, 
5%
 o
f t
he
 o
pi
oid
s 
de
pe
nd
en
t g
ro
up
for this tendency may be a greater focus on 
psychiatric comorbidity in the field of ED 
treatment and research than in the drug 
field. The drug field has traditionally been 
less focused on psychiatry, rather concen-
trating on educational, political and reli-
gious theories.
Stimulants and cannabis seem to be 
the most prevalent co-occurring drugs. 
Various writers have emphasised am-
phetamine and cocaine (Piran & Robinson 
2006; Cochrane et al. 1998) and to some 
extent ecstasy (Curran & Robjant 2006) in 
this context, recognising the appetite-de-
creasing effect of the use of these drugs. 
Other writers have called attention to 
methamphetamine, in particular, (Neale et 
al. 2009) as a drug that closely connects 
substance abuse and disordered eating be-
haviour.
Cannabis, on the other hand, is known 
to have appetite-increasing qualities, 
which could be associated more with 
binge eating or over-eating (e.g. Rodondi 
et al. 2006). When we see cannabis disor-
ders correlating to eating disorders in this 
review, it could be related to the position 
of cannabis as the most commonly used il-
licit drug in Europe (EMCDDA 2010) and 
USA (SAMHSA 2009). Reviewers Calero-
Elvira et al. (2009) offer another explana-
tion: they found raised levels of both opi-
ates and cannabis use among individuals 
with eating disorders, which suggests that 
the use of stimulants also requires the use 
of ”downers”, such as opiates or tranquil-
lisers. 
Regarding the different subtypes of eat-
ing disorders, the current review finds a 
stronger link between drug disorders and 
the diagnosis BN and the diagnosis AN, 
binge-eating/purging subtype, while the 
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link is weaker to the restricting subtype of 
Anorexia. This is in agreement with ear-
lier research (for example, Calero-Elvira et 
al. 2010; Holderness et al. 1994), although 
we still need more research on the connec-
tions between specific drugs and specific 
eating disorders.
Based on the findings of this review, 
some comments can be made on the etiol-
ogy of co-occurrence. A causal explanation 
that obtains some support in the reviewed 
studies is that eating disorders (AN or BN) 
can initiate the use of stimulants in order 
to suppress appetite (Newman & Gold 
1992; Hudson et al. 1992). More studies 
support theories of shared etiology, sug-
gesting impulsivity (Castro-Fornieles et 
al. 2010; Dohm et al. 2002), depression 
(Blinder et al. 2006; Herzog et al. 2006) or 
previous traumatic experiences (Blinder et 
al. 2006; Dohm et al. 2002) as underlying 
features influencing both eating disorders 
(in particular the bulimic type) and sub-
stance abuse.
Several studies find associations be-
tween substance abuse and Anorexia Ner-
vosa. Previous research shows that quite a 
few individuals with AN later develop BN 
(see Peat et al. 2009 for an overview). This 
calls for a broader look. Difficulties with 
regulating affects is suggested as a com-
mon trait in individuals with AN and sub-
stance abuse (Root et al. 2010b). The large 
variety of explanations could indicate that 
there are different explanations for differ-
ent groups of eating disorders and groups 
of substance use disorders (for instance, 
Carbaugh & Sias 2010; Root et al. 2010b; 
Cohen & Gordon 2009).
Limitations
As previous reviewers have pointed out, it 
is difficult to compare studies when crite-
ria vary considerably. When we keep the 
diagnostic criteria strict, the number of 
studies becomes rather low. Furthermore, 
the studies included employ different di-
agnostic categories of drug use disorders 
and eating disorders, and their samples 
vary in age. Also, the drug disorder diag-
noses in the studies are both lifetime and 
concurrent. These features make conclu-
sions uncertain.
Another more philosophical-methodo-
logical problem in both primary studies 
and reviews is that conclusions can only 
be drawn on the basis of what has been 
investigated. This leaves out large un-
investigated areas, such as men and eat-
ing disorders. When the instruments are 
not designed for men, or the samples do 
not include men, knowledge about men 
and comorbid ED and DUD will be lim-
ited. The current review therefore says 
less about men than about women in this 
respect. (It appears that this is slowly be-
ing rectified through increased interest in 
men’s eating disorders.)
Clinical implications
Even though the connections between eat-
ing disorders and substance abuse have 
been known for some time, current research 
shows that many addiction treatment pro-
grammes fail to offer both assessment and 
treatment based on this knowledge (Gordon 
et al. 2008). Prior research on order of on-
set (by, for example, Wolfe & Maisto 2000; 
Krahn 1993) implies that patients present-
ing for drug treatment may bring with 
them some sort of eating disorder. Stud-
ies of drug addicts in and after treatment 
reveal that eating symptomatology (Bonfa 
et al. 2008) and/or (excessive) weight gain 
Unauthenticated | 10.248.254.158
Download Date | 9/4/14 1:14 PM
310 NORDIC STUDIES ON ALCOHOL AND DRUGS   V O L .  2 9.  2 0 1 2  . 3
(Cowan & Devine 2008; Hodgkins et al. 
2003) may be partly to blame for dropout 
from treatment/taking up drugs again. Sev-
eral authors have suggested approaches 
in targeting co-occurring substance abuse 
and eating disorders, especially in the cog-
nitive-behavioural direction (Courbasson 
et al. 2011; Carbaugh & Sias 2010; Sysko 
& Hildebrandt 2009). Cohen and Gordon 
(2009) discuss the pros and cons of giving 
integrated, sequential or parallel treatment, 
while Harrop and Marlatt (2010) conclude 
that all research so far suggests integrated 
or simultaneous treatment. Recent research 
by Killeen et al. (2011) indicates a need for 
educating addiction treatment profession-
als in assessment, referral and treatment of 
eating disorders.  
Conclusion
This review set out to inspect studies of 
diagnostic eating disorders and drug use 
disorders, and found 13. The surveyed ED 
population report comorbidity between 
8 and 43 % for various lifetime drug dis-
orders, highlighting the factor of bulimia, 
binge eating and purging. The surveyed 
DUD population report 14 % of concur-
rent and 27.3 % of lifetime eating disor-
ders. Stimulant use is highlighted in this 
comorbidity.
It is noteworthy that 11 out of the 13 
studies – and all of the newer surveys – in 
this review have eating disorders as their 
departure point. This may suggest that 
the field of both research and treatment of 
drug disorders has not yet been sufficient-
ly interested in co-occurring eating disor-
ders. Future research calls for prevalence 
studies in the drug treatment field as well 
as for qualitative approaches exploring the 
interactions with drug disorders.
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 NOTE
1 Binge Eating Disorder is only included in 
the research section of DSM-IV (DSM-IV-
TR), but will probably be added in the new 
edition, DSM-V (www.dsm5.org).
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Appendix. The assortment process.
596 articles identified through database 
searches (including duplicates)
99 excluded because they studied 
non-relevant topics
91 excluded because they only 
examined alcohol use/abuse
406 articles on substance use/ abuse and 
eating disorders/ disordered eating
152 excluded because they did not 
measure diagnostic drug disorders, 
but either over-the counter medication, 
caffeine, tobacco, ”substances” (not 
distinguishing between alcohol and drugs), 
or sub-diagnostic use of drugs
43 excluded because they were treatment/
prevention studies
12 excluded because they were case 
studies
27 excluded because they measured 
non-diagnostic eating disorders
92 excluded because ED and DUD not 
seen in relation to one another but in  
relation to a third variable
42 excluded because they were 
theoretical studies
38 articles measuring diagnostic drug use 
disorders and eating disorders in the same 
sample
25 excluded because they were duplicates
13 articles remained
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